CSS
HSCS icon

Cubist Systematic Strategies’s Heart Test Laboratories HSCS Stock Holding History

Cubist Systematic Strategies’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-141
Closed -$1.65K – 3432
2024
Q1 		$1.65K Buy
+141
New +$1.84K ﹤0.01% 3587

Other funds holding HSCS

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CC
Cultivar Capital Denton, Texas $155M AUM 16.34% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cubist Systematic Strategies's HSCS Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Heart Test Laboratories (HSCS) in Q2 2024, closing a stake of 141 shares — an estimated $1.65K sold.

Cubist Systematic Strategies first reported a position in HSCS in Q1 2024 and held it in 1 quarter. The position peaked at $1.65K in Q1 2024. 7 funds tracked by Wall St. Rank hold HSCS as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Heart Test Laboratories position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 141 Heart Test Laboratories shares in Q2 2024, an estimated $1.65K.
  • Cubist Systematic Strategies first reported a position in Heart Test Laboratories in Q1 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's Heart Test Laboratories position peaked at $1.65K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.